Preservation Bio is a company focused on the development of a small molecule that inhibits RhoA, a protein involved in cell signaling. This molecule has the ability to reverse its effects, providing potential therapeutic applications in various diseases. By targeting RhoA, Preservation Bio aims to address conditions related to abnormal cell growth and migration, such as cancer and fibrosis. The company's innovative approach holds promise for the development of new treatments that could have a significant impact on patient outcomes.